PD
EW icon

Point72 (DIFC)’s Edwards Lifesciences EW Stock Holding History

Point72 (DIFC)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,100
Closed -$297K – 1721
2025
Q1 		$297K Sell
4,100
-89,700
-96% -$6.42M 0.01% 781
2024
Q4 		$6.94M Buy
93,800
+34,700
+59% +$2.43M 0.26% 93
2024
Q3 		$3.9M Buy
59,100
+55,700
+1,638% +$4.05M 0.13% 198
2024
Q2 		$314K Sell
3,400
-11,200
-77% -$992K 0.01% 761
2024
Q1 		$1.4M Buy
+14,600
New +$1.23M 0.04% 483

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Point72 (DIFC)'s EW Position: Q3 2025 in Review

Point72 (DIFC) increased its Edwards Lifesciences (EW) stake by 0.23% in Q3 2025, buying an estimated $69.3K and bringing the position to 386,867 shares worth $30.1M. The position accounts for 1.97% of the portfolio, ranked #6.

Point72 (DIFC) first reported a position in EW in Q3 2024 and has held it in 4 quarters since. The position peaked at $30.2M in Q2 2025. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Point72 (DIFC) held 386,867 shares of Edwards Lifesciences worth $30.1M as of Q3 2025.
  • Point72 (DIFC) bought 887 Edwards Lifesciences shares in Q3 2025, an estimated $69.3K.
  • Edwards Lifesciences made up 1.97% of Point72 (DIFC)'s portfolio in Q3 2025, its #6 holding.
  • Point72 (DIFC) first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s Edwards Lifesciences position peaked at $30.2M in Q2 2025.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.